ZA952405B - Solutions of dirithromycin - Google Patents

Solutions of dirithromycin

Info

Publication number
ZA952405B
ZA952405B ZA952405A ZA952405A ZA952405B ZA 952405 B ZA952405 B ZA 952405B ZA 952405 A ZA952405 A ZA 952405A ZA 952405 A ZA952405 A ZA 952405A ZA 952405 B ZA952405 B ZA 952405B
Authority
ZA
South Africa
Prior art keywords
dirithromycin
solutions
Prior art date
Application number
ZA952405A
Other languages
English (en)
Inventor
Stefan Leiner
Bernhard Hassel
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of ZA952405B publication Critical patent/ZA952405B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA952405A 1994-03-26 1995-03-24 Solutions of dirithromycin ZA952405B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4410637A DE4410637C1 (de) 1994-03-26 1994-03-26 Injizierbare Lösungen von Dirithromycin

Publications (1)

Publication Number Publication Date
ZA952405B true ZA952405B (en) 1995-09-26

Family

ID=6514000

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA952405A ZA952405B (en) 1994-03-26 1995-03-24 Solutions of dirithromycin

Country Status (7)

Country Link
EP (1) EP0754047A1 (fr)
JP (1) JPH09510722A (fr)
AU (1) AU2214195A (fr)
CO (1) CO4370014A1 (fr)
DE (1) DE4410637C1 (fr)
WO (1) WO1995026191A1 (fr)
ZA (1) ZA952405B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19518917A1 (de) * 1995-05-23 1996-11-28 Boehringer Ingelheim Vetmed Stabile, konzentrierte lokalverträgliche Erythromycylamin-Lösungen
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
KR101805087B1 (ko) * 2010-09-16 2017-12-05 주식회사 엘지화학 높은 방부력을 제공하는 오일 주사 제형

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DE3209429A1 (de) * 1982-03-16 1983-10-06 Boehringer Ingelheim Vetmed Mittel zur verbesserung der resorption von injizierten antibakteriell wirksamen substanzen und kombinationen, enthaltend ein benzyaminderivat
US4918108A (en) * 1982-03-16 1990-04-17 Boehringer Ingelheim Vetmedica Gmbh Method of improving the absorption of injected antibacterial substances
EP0473707A4 (en) * 1989-05-26 1992-12-09 Abbott Laboratories Injectable clarithromycin composition

Also Published As

Publication number Publication date
EP0754047A1 (fr) 1997-01-22
WO1995026191A1 (fr) 1995-10-05
CO4370014A1 (es) 1996-10-07
DE4410637C1 (de) 1995-09-21
AU2214195A (en) 1995-10-17
JPH09510722A (ja) 1997-10-28

Similar Documents

Publication Publication Date Title
DE59503739D1 (en) Polymer-sensor
GB2287879B (en) Baths
GB9418762D0 (en) Use of substituted cyclopentane-DI-and-triones
HU9700071D0 (en) Use of muramilpeptides
GB2289302B (en) Shower enclosures
ZA957632B (en) Sorpotions-kuehlaggregat
ZA952405B (en) Solutions of dirithromycin
GB2298947B (en) Artefact
AU122938S (en) Breadbox
GB2293321B (en) Bath
DE59508136D1 (en) Phenylthio-oxazolin-derivate
ZA965962B (en) Anti-piroplasmotic agent
HU9402476D0 (en) (piperidino-alkyl)-aryl-ethers
HU9401934D0 (en) Anti-freele solution
HU9401929D0 (en) Technical improvement of heat-airships
PL303744A1 (en) Antocorrosive agent
AU784P (en) BLONDIE Chamelaucium megalopetalum x uncinatum
CA73798S (en) Air-purifier
PL307196A1 (en) Pharmaceutcal agent
PL101014U1 (en) Small bathtub
TW303790U (en) Modified drawknife structure
GB9411448D0 (en) Bandages
ZA949591B (en) Parasite treating agent
GB9421078D0 (en) Tampons
GB9406177D0 (en) Bandage